Vertex Pharmaceuticals, Inc. (VRTX)
434.67
-2.28
(-0.52%)
USD |
NASDAQ |
May 18, 12:45
Vertex Pharmaceuticals Market Cap : 110.32B for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 174.66B |
| Biogen, Inc. | 28.49B |
| Gilead Sciences, Inc. | 162.01B |
| Regeneron Pharmaceuticals, Inc. | 65.96B |
| Moderna, Inc. | 19.18B |
Market Cap Related Metrics
| PE Ratio | 25.77 |
| PS Ratio | 9.060 |
| Price to Book Value | 5.698 |
| Price to Free Cash Flow | 30.13 |
| Price | 434.67 |
| Earnings Yield | 3.88% |
| Operating PE Ratio | 22.73 |
| Normalized PE Ratio | 25.24 |